CareDx (CDNA) Liabilities and Shareholders Equity (2013 - 2026)

CareDx (CDNA) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $411.1 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 16.05% year-over-year to $411.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 11.62% YoY) and the FY2025 annual result came in at $413.2 million, down 15.85% from the prior year.
• Liabilities and Shareholders Equity declined to $411.1 million in Q1 2026 per CDNA's latest filing, from $413.2 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $546.7 million in Q1 2022, with the low at $411.1 million in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $486.1 million, with a median of $489.6 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity grew 8.23% in 2025 and retreated 16.05% in 2026.
• CareDx's Liabilities and Shareholders Equity stood at $543.0 million in 2022, then retreated by 14.03% to $466.8 million in 2023, then rose by 5.19% to $491.0 million in 2024, then fell by 15.85% to $413.2 million in 2025, then dropped by 0.52% to $411.1 million in 2026.
• Business Quant data shows CDNA's Liabilities and Shareholders Equity at $411.1 million in Q1 2026, $413.2 million in Q4 2025, and $432.3 million in Q3 2025.